Thermo Fisher to Benefit as CMO Market Reaches $76.2B by 2035 at 13.7% CAGR
Global biopharmaceutical CMO market is forecast to grow from USD 21.16 billion in 2025 to USD 76.20 billion by 2035 at a 13.67% CAGR. North America holds 43.67% share while Asia Pacific leads fastest growth at 15.23% CAGR.
1. CMO Market Growth Forecast
The global biopharmaceutical contract manufacturing organization (CMO) market is expected to expand from USD 21.16 billion in 2025 to USD 76.20 billion by 2035, reflecting a compound annual growth rate of 13.67%. This surge is driven by increasing biologics development and capacity limitations at innovator companies.
2. Regional Market Breakdown
North America accounts for the largest portion with a 43.67% market share, underscoring established outsourcing demand in the region. Meanwhile, Asia Pacific is projected to grow at the fastest pace, registering a 15.23% CAGR as emerging markets and local CDMOs expand capacity.
3. Implications for Thermo Fisher
Thermo Fisher Scientific stands to capture a significant slice of this growth through its extensive global CMO infrastructure and service portfolio. Strategic investments to increase manufacturing capacity and partnerships in high-growth regions could enhance its revenue and margins.